Woodley Farra Manion Portfolio Management Inc increased Novartis A G (NVS) stake by 4.75% reported in 2017Q2 SEC filing. Woodley Farra Manion Portfolio Management Inc acquired 15,569 shares as Novartis A G (NVS)’s stock rose 4.17%. The Woodley Farra Manion Portfolio Management Inc holds 343,609 shares with $28.68M value, up from 328,040 last quarter. Novartis A G now has $198.87B valuation. The stock decreased 0.19% or $0.16 during the last trading session, reaching $83.8. About 1.13M shares traded. Novartis AG (NYSE:NVS) has risen 7.67% since December 12, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.
LivePerson, Inc. provides mobile and online business messaging solutions that power digital communication between brands and consumers. The company has market cap of $654.77 million. It operates in two divisions, Business and Consumer. It currently has negative earnings. The Business segment facilitates real-time online interactions, such as chat, voice, and content delivery across multiple channels and screens for firms of various sizes.
The stock decreased 1.35% or $0.15 during the last trading session, reaching $11. About 320,530 shares traded. LivePerson, Inc. (LPSN) has risen 55.95% since December 12, 2016 and is uptrending. It has outperformed by 39.25% the S&P500.
Awm Investment Company Inc. holds 3.92% of its portfolio in LivePerson, Inc. for 2.01 million shares. Rgm Capital Llc owns 2.67 million shares or 2.98% of their US portfolio. Moreover, Granahan Investment Management Inc Ma has 2.69% invested in the company for 2.66 million shares. The California-based Golden Gate Private Equity Inc. has invested 2.38% in the stock. Herald Investment Management Ltd, a United Kingdom-based fund reported 450,000 shares.
Analysts await LivePerson, Inc. (NASDAQ:LPSN) to report earnings on February, 14. They expect $-0.01 EPS, up 85.71% or $0.06 from last year’s $-0.07 per share. After $0.03 actual EPS reported by LivePerson, Inc. for the previous quarter, Wall Street now forecasts -133.33% negative EPS growth.
Among 16 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 4 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 34 analyst reports since July 28, 2015 according to SRatingsIntel. On Wednesday, April 5 the stock rating was downgraded by Cowen & Co to “Market Perform”. Mainfirst downgraded Novartis AG (NYSE:NVS) on Wednesday, October 28 to “Underperform” rating. On Friday, June 16 the stock rating was maintained by J P Morgan Chase Co with “Neutral”. The stock of Novartis AG (NYSE:NVS) earned “Hold” rating by Cowen & Co on Wednesday, August 9. Leerink Swann downgraded Novartis AG (NYSE:NVS) rating on Wednesday, March 23. Leerink Swann has “Market Perform” rating and $85 target. The stock has “Neutral” rating by Credit Suisse on Wednesday, January 11. The stock of Novartis AG (NYSE:NVS) has “Underperform” rating given on Wednesday, July 5 by Credit Suisse. The firm has “Overweight” rating given on Wednesday, July 26 by Morgan Stanley. As per Thursday, June 22, the company rating was maintained by Leerink Swann. The rating was maintained by Cowen & Co on Monday, July 10 with “Hold”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.